Diabetology and Metabolic Syndrome Q1
Unclaimed
BioMed Central Ltd
United Kingdom
Diabetology and Metabolic Syndrome is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 74. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1562 €. The scope of the journal is focused on diabetes, metabolic syndrome. It has an SJR impact factor of 1,152 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,152.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Price
1562 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,152
SJR Impact factor74
H Index308
Total Docs (Last Year)592
Total Docs (3 years)14758
Total Refs2443
Total Cites (3 years)588
Citable Docs (3 years)3.97
Cites/Doc (2 years)47.92
Ref/DocOther journals with similar parameters
Endocrine Reviews Q1
Nature Reviews Endocrinology Q1
Nature Metabolism Q1
Diabetes Care Q1
Bone Research Q1
Compare this journals
Aims and Scope
Diabetes
Metabolic syndrome
Comments